CD4 and cancer: Patients with malignancy of the lung, breast, colon, bladder, head–neck, prostate, rectum, and esophagus were found to have lower percentage of CD4+ and CD8+ T cells compared to those who had received four doses of the mRNA vaccine or those patients on hemodialysis [9].